Ishita Drugs & Industries Ltd

NSE: ISHITADR · BSE: 524400 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹74.50
Market cap: ₹22.28 Cr
Revenue (annual): ₹14.66 Cr
Net profit (annual): ₹0.78 Cr
P/E (TTM): 31.5×Sector 50.4×
Promoter holding: 50.04%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Debt & Borrowing 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

22 Sep 2026 15:27 IST BSE

Debt & Borrowing

Ishita Drugs & Industries Debt & Borrowing: ₹11.75 Cr

Ishita Drugs approved Rs.11.75 Crore borrowings from HDFC Bank, covering a term loan and working capital facility. This is within shareholder-approved borrowing limits from its 31st AGM.

Value: ₹11.75 Cr

Read the filing ↗

18 Sep 2026 18:19 IST BSE

Board Meeting Date

Ishita Drugs & Industries Board Meeting Date

Ishita Drugs & Industries Ltd will hold a board meeting on September 22, 2026. The meeting will consider raising funds through working capital and term loans.

Read the filing ↗

8 Aug 2026 15:35 IST BSE

Financial Results

Ishita Drugs & Industries Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 33.3% YoY

Ishita Drugs & Industries Ltd reported revenue from operations of ₹3.1 Cr (-42.6% YoY) and net profit of ₹0.2 Cr (-33.3% YoY) for Q1 FY27.

Key figure: Net profit ₹0.2 Cr · -33.3% YoY

Open full results → Read the filing ↗